Expired NOT-NS-22-026: Notice of Change to Key Dates for PAR-22-029 "Longitudinal Single Cell Characterization of ADRD Postmortem Tissue (R01 Clinical Trial Not Allowed)"

Notice of Change to Key Dates for PAR-22-029 "Longitudinal Single Cell Characterization of ADRD Postmortem Tissue (R01 Clinical Trial Not Allowed)"

Notice Number:

NOT-NS-22-026

Key Dates

Release Date:

September 14, 2021

Related Announcements

PAR-22-029 - Longitudinal Single Cell Characterization of ADRD Postmortem Tissue (R01 Clinical Trial Not Allowed)

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to extend the due date for PAR-22-029 "Longitudinal Single Cell Characterization of ADRD Postmortem Tissue (R01 Clinical Trial Not Allowed)". The new application due date is October 22, 2021. See below for changes to the Funding Opportunity Announcement (FOA).

Currently Reads:

Part 1. Overview Information

Key Dates:

Open Date: September 5, 2021

Application Due Dates			Review and Award Cycles
New	Renewal / Resubmission / Revision (as allowed)	AIDS	Scientific Merit Review	Advisory Council Review	Earliest Start Date
October 05, 2021 *	Not Applicable	Not Applicable	March 2022	May 2022	July 2022

Expiration Date October 6, 2021

Modified to Read:

Part 1. Overview Information

Key Dates:

Open Date: September 22, 2021

Application Due Dates			Review and Award Cycles
New	Renewal / Resubmission / Revision (as allowed)	AIDS	Scientific Merit Review	Advisory Council Review	Earliest Start Date
October 22, 2021 *	Not Applicable	Not Applicable	March 2022	May 2022	July 2022

Expiration Date October 23, 2021

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Daniel Miller, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-5680
Email: daniel.miller@nih.gov